Effect of hemodialysis on the plasma levels of clofarabine

Pediatr Blood Cancer. 2010 Jul 15;55(1):196-8. doi: 10.1002/pbc.22458.

Abstract

Clofarabine, a nucleoside analogue for treatment of relapsed leukemia, is 50-60% excreted in urine. Clofarabine has not been studied in patients on hemodialysis. We measured levels in one patient in acute renal failure. Prior to dialysis, 43 hr after a 40 mg/m(2) infusion, plasma concentration was 139 ng/ml. One hour after beginning hemodialysis, a 20 mg/m(2) infusion began. Plasma concentrations were 84.2, 81.1, and 88.0 ng/ml while the dialysis and clofarabine infusion occurred simultaneously. Post-dialysis, while the clofarabine was still infusing, the level was 95.8 ng/ml. Hemodialysis does decrease clofarabine levels, but given its large volume distribution, hemodialysis may not be effective for clofarabine overdose.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / therapy*
  • Adenine Nucleotides / blood*
  • Adenine Nucleotides / therapeutic use
  • Arabinonucleosides / blood*
  • Arabinonucleosides / therapeutic use
  • Clofarabine
  • Humans
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Renal Dialysis*
  • Treatment Outcome
  • Young Adult

Substances

  • Adenine Nucleotides
  • Arabinonucleosides
  • Clofarabine